Eric McDade on Toward an AD CRISPR Therapy: Tweaking APP Terminus Cuts Plaque
COMMENT Subhojit Roy and his team report exciting transgenic-mouse work, targeting the amyloid precursor protein (APP) with CRISPR-Cas9/AAV. This follows nicely on Dr. Roy’s cell-based work and provides promising, preliminary evidence for using this approach to t